On a preliminary basis, the Company expects unaudited GROSS REVENUESfor the three months ended March 31, 2011 of approximately $3,400,000, an INCREASE OF APPROXIMATELY 272% as compared to gross revenues of $1,258,588 during the corresponding three month period ended March 31, 2010.
GROSS MARGINS for the first quarter of 2011 are expected to have INCREASED TO APPROXIMATELY 40% or $1,360,000.00, as compared to gross margins of approximately 30% or $380,000 in the first quarter of 2010.
The Company incurred advertising expenses of approximately $700,000 during the three months ended March 31, 2011. The Company had approximately $330,000 in cash on hand as of March 31, 2011, a FINANCIALLY HEALTHIER POSITION as compared to cash overdrafts of (40,000) as of March 31, 2010.
MusclePharm To Be In Attendance At the 2011 FIBO Expo, The Largest International Health and Fitness Trade Show Date: 04/14/2011 @ 8:30AM Source: PR Newswire Stock: (MSLP) http://ih.advfn.com/p.php?pid=nmona&article=47295256
ABOUT MSLP Headquartered in Denver, Colorado, MusclePharm is a rapidly expanding healthy life-style company that develops and manufactures a full line of NSF and scientifically approved nutritional supplements that are 100% free of any banned substances. Based on years of research, MusclePharm products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists, and field tested by more than 100 elite professional athletes from various sports including the NFL, MMA, and MLB. The Company's propriety and award winning products address all categories of an active lifestyle including muscle building, weight loss, and maintaining general fitness through a daily nutritional supplement regimen. MusclePharm is sold in over 120 countries and available in over 5,000 U.S. retail outlets that include GNC and Vitamin Shoppe, as well as over 100 online stores, including bodybuilding.com, Amazon and Vitacost.com.
SOME TECHNICAL INFO INVESTOR RELATIONS Contact our Investor Relations Department directly for any information regarding MusclePharm® Corporation. EMAIL IR: investors@musclepharm.com
REGISTRAR AND TRANSFER AGENT Corporate Stock Transfer, Inc. 3200 Cherry Creek Dr. South, Suite 430 Denver, CO. 80209 (P) 303.282.4800 (F) 303.282.5800 (E) cbell@corporatestock.com
LEGAL DEPARTMENT GENERAL COUNSEL Mark Campanini 3390 Peoria St. #307 Aurora, CO 80010 (P) 1800.210.7369 (F) 1800.490.7165 (E) mcampanini@musclepharm.com